{
    "clinical_study": {
        "@rank": "9805", 
        "arm_group": [
            {
                "arm_group_label": "nitrofurantoin 100 mg", 
                "arm_group_type": "Active Comparator"
            }, 
            {
                "arm_group_label": "Ciprofloxacin 250 mg", 
                "arm_group_type": "Active Comparator"
            }
        ], 
        "brief_summary": {
            "textblock": "Pilot study to compare the efficacy and safety of 3-day, twice-daily regimens of\n      nitrofurantoin and ciprofloxacin in emergency department (ED) patients presenting with UBC."
        }, 
        "brief_title": "A Pilot Comparison of Short-course Nitrofurantoin in Females With Uncomplicated Bacterial Cystitis in the Emergency Department", 
        "completion_date": {
            "#text": "January 2012", 
            "@type": "Actual"
        }, 
        "condition": "Uncomplicated Bacterial Cystitis", 
        "condition_browse": {
            "mesh_term": "Cystitis"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  pre-menopausal females\n\n          -  ages 18-45 years old\n\n          -  symptoms of a UTI (dysuria, frequency, urgency)\n\n        Exclusion Criteria:\n\n          -  Onset of symptoms >7 days prior to the ED visit\n\n          -  Non-English speaking\n\n          -  Symptoms of pyelonephritis\n\n          -  Diabetic\n\n          -  Indications of sepsis\n\n          -  Immunocompromised\n\n          -  Currently using prophylactic antimicrobials\n\n          -  Medications that could interfere with study drug\n\n          -  Pregnant\n\n          -  Lactating\n\n          -  History of kidney or liver disease\n\n          -  Vaginal symptoms\n\n          -  Presence of a urinary catheter\n\n          -  Treatment for UBC <2 weeks prior to ED visit\n\n          -  Known allergy to study drug\n\n          -  Unavailable for follow-up"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "45 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "36", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "December 11, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01749605", 
            "org_study_id": "201005757"
        }, 
        "intervention": [
            {
                "arm_group_label": "nitrofurantoin 100 mg", 
                "intervention_name": "Nitrofurantoin monohydrate/macrocrystals 100 mg BID x 3 days", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Ciprofloxacin 250 mg", 
                "intervention_name": "ciprofloxacin 250 mg BID x 3 days", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Ciprofloxacin", 
                "Nitrofurantoin"
            ]
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "lastchanged_date": "December 12, 2012", 
        "location": {
            "facility": {
                "address": {
                    "city": "Iowa City", 
                    "country": "United States", 
                    "state": "Iowa", 
                    "zip": "52242"
                }, 
                "name": "University of Iowa Hospitals and Clinics"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: University of Iowa Institutional Review Boards", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "January 2012", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "7-day questionnaires included a table to measure the severity of the symptoms and their impact on daily life. Using this table, the investigators calculated a severity score (left hand column) and a bothersome score (right hand column), with a maximum score of 21", 
            "measure": "clinical cure at 7 days", 
            "safety_issue": "No", 
            "time_frame": "7 days"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01749605"
        }, 
        "responsible_party": {
            "investigator_affiliation": "University of Iowa", 
            "investigator_full_name": "Brett A Faine", 
            "investigator_title": "Clinical Pharmacy Specialist", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "University of Iowa", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University of Iowa", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "October 2010", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "December 2012"
    }
}